🚀 VC round data is live in beta, check it out!
Laboratorio Farmaceutico Valuation Multiples
Discover revenue and EBITDA valuation multiples for Laboratorio Farmaceutico and similar public comparables like Amatheon Agri Holding, Ecomiam, New Nordic Healthbrands, Fountain and more.
Laboratorio Farmaceutico Overview
About Laboratorio Farmaceutico
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.
Founded
N/A
HQ
Employees
33
Website
Sectors
Financials (FY)
EV
$13M
Laboratorio Farmaceutico Financials
Laboratorio Farmaceutico reported last fiscal year revenue of $7M and EBITDA of $1M.
In the same fiscal year, Laboratorio Farmaceutico generated $5M in gross profit, $1M in EBITDA, and $422K in net income.
Laboratorio Farmaceutico P&L
In the most recent fiscal year, Laboratorio Farmaceutico reported revenue of $7M and EBITDA of $1M.
Laboratorio Farmaceutico expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $7M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $5M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 72% | XXX | XXX | XXX |
| EBITDA | — | XXX | $1M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 21% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 10% | XXX | XXX | XXX |
| Net Profit | — | XXX | $422K | XXX | XXX | XXX |
| Net Margin | — | XXX | 6% | XXX | XXX | XXX |
| Net Debt | — | — | $7K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Laboratorio Farmaceutico Stock Performance
Laboratorio Farmaceutico has current market cap of $12M, and enterprise value of $13M.
Market Cap Evolution
Laboratorio Farmaceutico's stock price is $1.39.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13M | $12M | 0.6% | XXX | XXX | XXX | $0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLaboratorio Farmaceutico Valuation Multiples
Laboratorio Farmaceutico trades at 1.8x EV/Revenue multiple, and 8.9x EV/EBITDA.
Laboratorio Farmaceutico Financial Valuation Multiples
As of March 19, 2026, Laboratorio Farmaceutico has market cap of $12M and EV of $13M.
Equity research analysts estimate Laboratorio Farmaceutico's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Laboratorio Farmaceutico has a P/E ratio of 28.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $12M | XXX | $12M | XXX | XXX | XXX |
| EV (current) | $13M | XXX | $13M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 8.9x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 18.3x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.5x | XXX | XXX | XXX |
| P/E | — | XXX | 28.1x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 15.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Laboratorio Farmaceutico Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Laboratorio Farmaceutico Margins & Growth Rates
Laboratorio Farmaceutico's revenue in the last fiscal year grew by 2%.
Laboratorio Farmaceutico Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 21% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (21%) | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 62% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Laboratorio Farmaceutico Public Comps
See public comps and valuation multiples for other Food & Beverages comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Amatheon Agri Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| Ecomiam | XXX | XXX | XXX | XXX | XXX | XXX |
| New Nordic Healthbrands | XXX | XXX | XXX | XXX | XXX | XXX |
| Fountain | XXX | XXX | XXX | XXX | XXX | XXX |
| Willamette Valley | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Laboratorio Farmaceutico M&A Activity
Laboratorio Farmaceutico acquired XXX companies to date.
Last acquisition by Laboratorio Farmaceutico was on XXXXXXXX, XXXXX. Laboratorio Farmaceutico acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Laboratorio Farmaceutico
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLaboratorio Farmaceutico Investment Activity
Laboratorio Farmaceutico invested in XXX companies to date.
Laboratorio Farmaceutico made its latest investment on XXXXXXXX, XXXXX. Laboratorio Farmaceutico invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Laboratorio Farmaceutico
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Laboratorio Farmaceutico
| Where is Laboratorio Farmaceutico headquartered? | Laboratorio Farmaceutico is headquartered in Italy. |
| How many employees does Laboratorio Farmaceutico have? | As of today, Laboratorio Farmaceutico has over 33 employees. |
| Is Laboratorio Farmaceutico publicly listed? | Yes, Laboratorio Farmaceutico is a public company listed on Borsa Italiana. |
| What is the stock symbol of Laboratorio Farmaceutico? | Laboratorio Farmaceutico trades under ERFO ticker. |
| When did Laboratorio Farmaceutico go public? | Laboratorio Farmaceutico went public in 2022. |
| Who are competitors of Laboratorio Farmaceutico? | Laboratorio Farmaceutico main competitors are Amatheon Agri Holding, Ecomiam, New Nordic Healthbrands, Fountain. |
| What is the current market cap of Laboratorio Farmaceutico? | Laboratorio Farmaceutico's current market cap is $12M. |
| What is the current revenue of Laboratorio Farmaceutico? | Laboratorio Farmaceutico's last fiscal year revenue is $7M. |
| What is the current EV/Revenue multiple of Laboratorio Farmaceutico? | Current revenue multiple of Laboratorio Farmaceutico is 1.8x. |
| Is Laboratorio Farmaceutico profitable? | No, Laboratorio Farmaceutico is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.